Andrew Obenshain, President and CEO at bluebird bio, Inc. (BLUE), sold 1,263 shares at $6.41 ($8K) on 2022-11-04, disclosed to the SEC on 2022-11-08.
Open-market sale of $8k BLUE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLUE | SELL | 2025-01-08 | $1K | — | Filing → |
| BLUE | SELL | 2024-12-12 | $408 | — | Filing → |
| BLUE | SELL | 2024-10-02 | $18K | — | Filing → |